Search research articles
Contact Us
Filters
Showing results (221-230 of 240) with videos related to
Page
of 24
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 14, 2022
Preoperative Chemoradiotherapy With Capecitabine With or Without Temozolomide in Patients With Locally Advanced Rectal Cancer: A Prospective, Randomised Phase II Study Stratified by O<sup>6</sup>-Methylguanine DNA Methyltransferase Status: KCSG-CO17-02
C R Oh, J E Kim, J S Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2026
A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3
S Kopetz, J Tabernero, S Lonardi, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
August 17, 2005
Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus
Garth L Warnock, R Mark Meloche, David Thompson, et al.
British Journal of Cancer
|
October 28, 2015
A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
S H Lim, T W Kim, Y S Hong, et al.
British Journal of Cancer
|
March 2, 2013
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)
Y-K Kang, H-M Chang, J H Yook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2024
Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study
T André, K-K Shiu, T W Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 20, 2018
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study
T Yoshino, D C Portnoy, R Obermannová, et al.
Oncogene
|
May 31, 2016
Foxp3 is a key downstream regulator of p53-mediated cellular senescence
J-E Kim, J-S Shin, J-H Moon, et al.
Oncogenesis
|
January 17, 2017
API5 confers cancer stem cell-like properties through the FGF2-NANOG axis
K-H Song, H Cho, S Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 29, 2019
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors
M D Hellmann, T-W Kim, C B Lee, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 240) with videos related to
Sort By:
Page
of 24
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 14, 2022
Preoperative Chemoradiotherapy With Capecitabine With or Without Temozolomide in Patients With Locally Advanced Rectal Cancer: A Prospective, Randomised Phase II Study Stratified by O<sup>6</sup>-Methylguanine DNA Methyltransferase Status: KCSG-CO17-02
C R Oh, J E Kim, J S Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2026
A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3
S Kopetz, J Tabernero, S Lonardi, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
August 17, 2005
Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus
Garth L Warnock, R Mark Meloche, David Thompson, et al.
British Journal of Cancer
|
October 28, 2015
A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
S H Lim, T W Kim, Y S Hong, et al.
British Journal of Cancer
|
March 2, 2013
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)
Y-K Kang, H-M Chang, J H Yook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2024
Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study
T André, K-K Shiu, T W Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 20, 2018
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study
T Yoshino, D C Portnoy, R Obermannová, et al.
Oncogene
|
May 31, 2016
Foxp3 is a key downstream regulator of p53-mediated cellular senescence
J-E Kim, J-S Shin, J-H Moon, et al.
Oncogenesis
|
January 17, 2017
API5 confers cancer stem cell-like properties through the FGF2-NANOG axis
K-H Song, H Cho, S Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 29, 2019
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors
M D Hellmann, T-W Kim, C B Lee, et al.
Page
of 24